Contineum Therapeutics, Inc. (CTNM) Tops Q4 EPS by 16c

Contineum Therapeutics, Inc. (NASDAQ: CTNM) reported Q4 EPS of ($0.49), $0.16 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Contineum Therapeutics, Inc. (CTNM) click here.

You May Also Be Interested In

• XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
• Workday (WDAY) PT Raised to $220 at Oppenheimer
• Comstock closes $45M mining asset sale, receives $20M cash